Advertisement
Canada markets close in 2 hours 25 minutes
  • S&P/TSX

    22,161.71
    +54.63 (+0.25%)
     
  • S&P 500

    5,248.97
    +0.48 (+0.01%)
     
  • DOW

    39,746.65
    -13.43 (-0.03%)
     
  • CAD/USD

    0.7389
    +0.0017 (+0.23%)
     
  • CRUDE OIL

    82.78
    +1.43 (+1.76%)
     
  • Bitcoin CAD

    95,700.93
    +2,178.47 (+2.33%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,238.70
    +26.00 (+1.18%)
     
  • RUSSELL 2000

    2,125.45
    +11.10 (+0.53%)
     
  • 10-Yr Bond

    4.2020
    +0.0060 (+0.14%)
     
  • NASDAQ

    16,371.44
    -28.08 (-0.17%)
     
  • VOLATILITY

    13.00
    +0.22 (+1.72%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6839
    +0.0034 (+0.50%)
     

RDInvesting Provides Investors with Free In-Depth Equity Reports on INSM, KBH, MDRX and SWKS

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Insmed Inc. (NASDAQ:INSM - News) shares declined 5.18 percent to close at $18.12 a share Tuesday. The stock traded between $16.49 and $18.19 on volume of 1.98 million shares traded. Analysts at Wedbush have recently downgraded the company’s rating to "underperform" from "outperform". Shares of Insmed have gained approximately 6.0 percent year-to-date.

Find out more about Insmed including full access to the free equity report at:
www.RDInvesting.com/INSM

KB Home (NYSE:KBH - News) shares declined 1.32 percent to close at $18.63 a share Tuesday. The stock traded between $18.40 and $18.70 on volume of 3.62 million shares traded. Analysts at Raymond James have recently downgraded the company’s rating to "underperform" from "market perform". Shares of KB Home have gained approximately 2.0 percent year-to-date.

ADVERTISEMENT

Find out more about KB Home including full access to the free equity report at:
www.RDInvesting.com/KBH

Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX - News) shares increased 2.84 percent to close at $16.68 a share Tuesday. The stock traded between $16.56 and $16.93 on volume of 2.02 million shares traded. Analysts at Maxim Group have recently upgraded the company’s rating to "buy" from "hold". Shares of Allscripts have gained approximately 8.0 percent year-to-date.

Find out more about Allscripts including full access to the free equity report at:
www.RDInvesting.com/MDRX

Skyworks Solutions Inc. (NASDAQ:SWKS - News) shares increased 1.27 percent to close at $31.09 a share Tuesday. The stock traded between $30.66 and $31.58 on volume of 3.38 million shares traded. Analysts at Standpoint Research have recently downgraded the company’s rating to "hold" from "buy". Shares of Skyworks Solutions have gained approximately 8.0 percent year-to-date.

Find out more about Skyworks Solutions including full access to the free equity report at:
www.RDInvesting.com/SWKS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com